With the variance in survival rates so dependent on type, insurers underwriting clients with brain tumours must stay informed on all the relevant statistics. Angela Kidd provides the details.
There were around 4,300 tumours of the brain and central nervous system (CNS) diagnosed in the UK in 2003. Brain tumours include those that develop within the brain, namely primary tumours and those that metastasise from other parts of the body, so called secondary tumours. Primary brain tumours develop from brain cells and can be either benign or malignant. Benign tumours remain in the part of the brain in which they started and do not spread into and destroy other areas of the brain tissue or other parts of the body. Malignant primary brain tumours are most likely to cause proble...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes